Last reviewed · How we verify

NCT03801486

Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

Completed Last updated 30 October 2023
What this trial tests

trial testing Experimental: Sprouted Chickpea Flour in Endothelial Dysfunction in 34 participants. Completed in 1 May 2017.

Timeline
2 March 2016
Primary endpoint
1 May 2017
1 May 2017

Quick facts

Lead sponsorMontclair State University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date2 March 2016
Primary completion1 May 2017
Estimated completion1 May 2017

Drugs / interventions tested

Conditions studied

Sponsor

Montclair State University

Who can join

Adults 18 to 50, any sex, with Endothelial Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators examined the effects on post-digestion brachial artery flow mediated dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with sprouted chickpea flour.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Incorporating sprouted chickpea flour in pasta increases brachial artery flow-mediated dilation.
    Bruno JA, Feldman CH, Konas DW, Kerrihard AL, et al · · 2019 · cited 3× · PMID 31564118 · DOI 10.1556/2060.106.2019.21

Verify or expand the search:

Other recruiting trials for Endothelial Dysfunction

Currently open trials in the same condition.

Other Montclair State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03801486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing